ABVC BioPharma Inc

ABVC

Company Profile

  • Business description

    ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.

  • Contact

    44370 Old Warm Springs Boulevard
    FremontCA94538
    USA

    T: +1 510 668-0881

    E: [email protected]

    https://www.abvcpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    19

Stocks News & Analysis

stocks

Why don’t good returns guarantee a 5-star rating?

Amy Arnott explains how Morningstar’s stock ratings work.
stocks

Despite post earnings rally ASX share still cheap

Lifting our 2028 earnings estimate by 20%.
stocks

Overvalued ASX share has overly ambitious profit target

We think the new profit target is aggressive and unlikely to be met.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,968.7028.60-0.32%
CAC 408,216.78135.22-1.62%
DAX 4026,045.37553.27-2.08%
Dow JONES (US)50,759.42848.75-1.64%
FTSE 10010,689.87191.68-1.76%
HKSE23,391.29116.88-0.50%
NASDAQ24,328.38181.38-0.74%
Nikkei 22558,461.82398.61-0.68%
NZX 50 Index14,343.4736.510.26%
S&P 5007,340.5376.06-1.03%
S&P/ASX 2008,854.4028.80-0.32%
SSE Composite Index3,584.740.160.00%

Market Movers